Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 12 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (9)
P 1 (1)
P 2 (1)
P 3 (1)

Trial Status

Completed9
Active Not Recruiting1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06628323Not ApplicableActive Not RecruitingPrimary

Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations

NCT07134816Not ApplicableNot Yet RecruitingPrimary

Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder

NCT06155695Not ApplicableCompletedPrimary

Auditory Control Enhancement (ACE) in Schizophrenia

NCT04661163Not ApplicableCompletedPrimary

CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy

NCT02670291Not ApplicableCompletedPrimary

Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation

NCT02567500Not ApplicableCompletedPrimary

The Physalis Child : Identification of Cognitive and Emotional Factors

NCT00870909Not ApplicableCompleted

Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia

NCT02240446Not ApplicableWithdrawnPrimary

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients

NCT01963676Not ApplicableCompleted

Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia

NCT01478880Phase 2CompletedPrimary

Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations

NCT01015001Phase 3Completed

A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine

NCT00763841Phase 1CompletedPrimary

Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations

Showing all 12 trials

Research Network

Activity Timeline